Organic compounds -- part of the class 532-570 series – Organic compounds – Rare earth containing
Reexamination Certificate
2006-02-22
2009-10-20
Jones, D L (Department: 1618)
Organic compounds -- part of the class 532-570 series
Organic compounds
Rare earth containing
C424S001110, C424S001650, C424S001810
Reexamination Certificate
active
07605239
ABSTRACT:
The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
REFERENCES:
patent: 3032584 (1962-05-01), Bergel et al.
patent: 3032585 (1962-05-01), Bergel et al.
patent: 3398198 (1968-08-01), Kersnar et al.
patent: 3726912 (1973-04-01), McCrary et al.
patent: 3852414 (1974-12-01), Alder et al.
patent: 3931396 (1976-01-01), Bardy et al.
patent: 3965254 (1976-06-01), Tofe et al.
patent: 3974268 (1976-08-01), Subramanian et al.
patent: 3989730 (1976-11-01), Subramanian et al.
patent: 4017596 (1977-04-01), Loberg et al.
patent: 4058704 (1977-11-01), Shimizu
patent: 4075314 (1978-02-01), Wolfangel et al.
patent: 4104366 (1978-08-01), Schmidt-Dunker et al.
patent: 4187284 (1980-02-01), Rolleston et al.
patent: 4399817 (1983-08-01), Benedict
patent: 4508625 (1985-04-01), Graham
patent: 4515767 (1985-05-01), Simon et al.
patent: 4560548 (1985-12-01), Simon et al.
patent: 4606907 (1986-08-01), Simon et al.
patent: 4639365 (1987-01-01), Sherry
patent: 4647447 (1987-03-01), Gries et al.
patent: 4678667 (1987-07-01), Meares et al.
patent: 4707353 (1987-11-01), Bugaj et al.
patent: 4752464 (1988-06-01), Lieberman et al.
patent: 4808541 (1989-02-01), Mikola et al.
patent: 4853209 (1989-08-01), Kaplan et al.
patent: 4882142 (1989-11-01), Simon et al.
patent: 4885363 (1989-12-01), Tweedle et al.
patent: 4897254 (1990-01-01), Simon et al.
patent: 4897255 (1990-01-01), Fritzberg et al.
patent: 4898724 (1990-02-01), Simon et al.
patent: 4937333 (1990-06-01), Garlich et al.
patent: 4957939 (1990-09-01), Gries et al.
patent: 4976950 (1990-12-01), Simon et al.
patent: 5059412 (1991-10-01), Simon et al.
patent: 5064633 (1991-11-01), Simon et al.
patent: 5066478 (1991-11-01), Simon et al.
patent: 5089249 (1992-02-01), Fritzberg et al.
patent: 5202109 (1993-04-01), Fritzberg et al.
patent: 5219556 (1993-06-01), Wolfangel
patent: 5286497 (1994-02-01), Hendrickson et al.
patent: 5300279 (1994-04-01), Simon et al.
patent: 5393512 (1995-02-01), Vanderheyden et al.
patent: 5587451 (1996-12-01), Athey et al.
patent: 5621001 (1997-04-01), Canetta et al.
patent: 5630996 (1997-05-01), Reno et al.
patent: 5641803 (1997-06-01), Canetta et al.
patent: 5665761 (1997-09-01), Canetta et al.
patent: 5670537 (1997-09-01), Canetta et al.
patent: 5679318 (1997-10-01), Vanderheyden et al.
patent: 5707610 (1998-01-01), Ibsen et al.
patent: 5708169 (1998-01-01), Hester, Jr. et al.
patent: 5712275 (1998-01-01), Van Gestel
patent: 5714467 (1998-02-01), Boman et al.
patent: 5714504 (1998-02-01), Lindberg et al.
patent: 5714604 (1998-02-01), Kiefer
patent: 5756472 (1998-05-01), Liesch et al.
patent: 5756505 (1998-05-01), Nishino et al.
patent: 5756685 (1998-05-01), Fritzberg et al.
patent: 5756725 (1998-05-01), Wilkening et al.
patent: 5760063 (1998-06-01), Lam et al.
patent: 5762907 (1998-06-01), Simon et al.
patent: 5770617 (1998-06-01), LaVoie et al.
patent: 5773421 (1998-06-01), Alder et al.
patent: 5773443 (1998-06-01), Ray et al.
patent: 5773696 (1998-06-01), Liang et al.
patent: 5783570 (1998-07-01), Yokota et al.
patent: 5786325 (1998-07-01), Borromeo et al.
patent: 5801172 (1998-09-01), Clapp-Shapiro et al.
patent: 5807854 (1998-09-01), Bartroli et al.
patent: 5814634 (1998-09-01), Nishino et al.
patent: 5824698 (1998-10-01), Hasler et al.
patent: 5824874 (1998-10-01), Ulbrich et al.
patent: 5830855 (1998-11-01), Takemoto
patent: 5830889 (1998-11-01), Iwata et al.
patent: 5837253 (1998-11-01), Cohen
patent: 5837726 (1998-11-01), Liu et al.
patent: 5849956 (1998-12-01), Koga et al.
patent: 5854213 (1998-12-01), Bouffard
patent: 5854280 (1998-12-01), Gomez et al.
patent: 5856347 (1999-01-01), Hashiguchi et al.
patent: 5859032 (1999-01-01), Nishino et al.
patent: 5861430 (1999-01-01), Markonius
patent: 5863773 (1999-01-01), Gunawardana et al.
patent: 5866549 (1999-02-01), Or et al.
patent: 5872249 (1999-02-01), Park et al.
patent: 5876738 (1999-03-01), Ohno et al.
patent: 5888526 (1999-03-01), Tsubai et al.
patent: 5888941 (1999-03-01), Bartroli et al.
patent: 5891890 (1999-04-01), Nishino et al.
patent: 5908862 (1999-06-01), Wai Lee et al.
patent: 5910498 (1999-06-01), Yazaki et al.
patent: 5917084 (1999-06-01), Jiang
patent: 5919438 (1999-07-01), Saint-Leger
patent: 5919925 (1999-07-01), Burton et al.
patent: 6005083 (1999-12-01), Kasina
patent: 6177551 (2001-01-01), Kasina
patent: 6187910 (2001-02-01), Kasina
patent: 6241961 (2001-06-01), Benes et al.
patent: 6528627 (2003-03-01), Kasina
patent: 6767531 (2004-07-01), Fritzberg et al.
patent: 7070759 (2006-07-01), Fritzberg et al.
patent: 7094885 (2006-08-01), Fritzberg
patent: 7097823 (2006-08-01), Fritzberg et al.
patent: 7115720 (2006-10-01), Fritzberg
patent: 7378077 (2008-05-01), Fritzberg et al.
patent: 7408046 (2008-08-01), Fritzberg et al.
patent: 2002/0176818 (2002-11-01), Fritzberg et al.
patent: 2003/0118508 (2003-06-01), Simon et al.
patent: 2003/0158393 (2003-08-01), Kasina
patent: 2004/0096393 (2004-05-01), Fritzberg
patent: 2004/0126317 (2004-07-01), Fritzberg
patent: 2005/0063905 (2005-03-01), Fritzberg et al.
patent: 2005/0238578 (2005-10-01), Fritzberg et al.
patent: 2007/0053833 (2007-03-01), Fritzberg et al.
patent: 2008/0279773 (2008-11-01), Fritzberg
patent: 1078731 (1980-06-01), None
patent: 0164843 (1985-12-01), None
patent: 0210043 (1987-01-01), None
patent: 0232751 (1987-08-01), None
patent: 0255471 (1988-02-01), None
patent: 0258616 (1988-03-01), None
patent: 0287465 (1988-10-01), None
patent: 0374501 (1990-06-01), None
patent: 0382582 (1990-08-01), None
patent: 0408701 (1991-01-01), None
patent: 0411941 (1991-02-01), None
patent: 0455380 (1991-11-01), None
patent: 0698029 (1996-02-01), None
patent: 0972528 (2000-01-01), None
patent: 2230374 (1974-12-01), None
patent: WO-84/03698 (1984-09-01), None
patent: WO-90/06776 (1990-06-01), None
patent: WO-91/16075 (1991-10-01), None
patent: WO-93/25240 (1993-12-01), None
patent: WO-94/26753 (1994-11-01), None
patent: WO-95/10940 (1995-04-01), None
patent: WO-98/43678 (1998-10-01), None
patent: WO-00/76556 (2000-12-01), None
patent: WO-01/91806 (2001-12-01), None
patent: WO-02/062398 (2002-08-01), None
Bai et al, Journal of Radioanalytical and Nuclear Chemistry, 1998, vol. 236, Nos. 1-2, pp. 87-95.
“Abstract Book, Annual Congress of the EANM”,European Journal of Nuclear Medicine and Molecular Imaging, 31, Helsinki, 2004, including abstracts P908, P925-P936, and P946-P952,(2004).
“Bone Cancer Therapy Project Funding Awarded to Brookhaven National Laboratory for Diatide-Licensed Product”, Distribution: Business Editors and Health/Medical Writers,(1999).
“Breast Cancer; Genitourinary Cancer; Multiple Myeloma”,Annotated Guide to Cancer Chemotherapeutic Regimens 1999/2000, Oncology Special Edition, 13-14; 17-18; 32.
“Chapter III: Chemotherapy Regimens in Adults”,In Cancer Chemotherapy Pocket Guide,Robert J. Ignoffo, Editor,(1998),248-255; 338-341.
“Manufacture of Triethylene Tetramine”,Research Disclosure, 315, No. 31591,(1990),595.
“Multiple Myeloma”,In Clinical Oncology, A Multidisciplinary Approach for Physicans and Students, 7th Edition, Philip Rubin, Editor,(1993),239-244.
“NeoRx Updates Skeletal Targeted Radiotherapy (STR) Phase I/II Trail Data”,NeoRx Press Release, (May 7, 2001).
“NeoRx's Multiple Myeloma Study with Targeted Radiotherapy to be Updated at ASH—Recent Thalidomide Results Heighten Interest in New Multiple Myeloma Therapies”,NeoRx Press Release, (Nov. 30, 1999).
“NeoRx's Targeted Radiotherapy Achieves Complete Responses with Excellent Safety in Multiple Myeloma Patients”,NeoRx Press Release, (Dec. 7, 1999).
“Phase I/II Interim Data on NeoRx's STR Product in Multiple Myeloma”,NeoRx Press Release, (1999).
Abrams, Paul
Jones D L
Poniard Pharmaceuticals, Inc.
Schwegman Lunberg & Woessner, P.A.
LandOfFree
Skeletal-targeted radiation to treat bone-associated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Skeletal-targeted radiation to treat bone-associated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Skeletal-targeted radiation to treat bone-associated... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4081915